Recent News

• 03.30.2026 - CANOPY GROWTH’S APOLLO CANNABIS CLINICS NAMED BEST MEDICAL CANNABIS CLINIC
• 03.27.2026 - CANOPY GROWTH ANNOUNCES STORZ & BICKEL EXECUTIVE TRANSITION
• 03.16.2026 - Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada’s Leading Medical Cannabis Business By Revenue
• 02.18.2026 - Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition
• 02.06.2026 - Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results; Delivers double digit net revenue growth in Canada Cannabis contributing to a narrowing net loss; financial strength of $371M in cash and cash equivalents with a net cash position of $146M at December 31, 2025
• 01.23.2026 - Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026

Recent Filings

• 03.16.2026 - EX-99.1 EX-99.1
• 03.16.2026 - 8-K Current report
• 02.13.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.13.2026 - EFFECT Notice of Effectiveness
• 02.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2026 - S-3 Registration statement under Securities Act of 1933
• 02.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.06.2026 - EX-99.1 EX-99.1
• 02.06.2026 - 8-K Current report
• 01.15.2026 - 424B3 Prospectus [Rule 424(b)(3)]